
    
      Aim 1: To evaluate the safety and tolerability of three different lactoferrin/FOS doses in
      preterm infants

        1. Lactoferrin/FOS related adverse events and serious adverse events

        2. Time reaching full feeds while receiving lactoferrin/FOS (120 ml/kg/day)

        3. Episodes of not receiving enteral feedings for > 24 hours once feeding is initiated

      Aim 2: To evaluate lactoferrin/FOS absorption and excretion

        1. Examine lactoferrin/FOS levels in saliva, urine, plasma, and stool

        2. Examine lactoferrin levels in materal and human donor milk

      Aim 3: To evaluate the effect of lactoferrin/FOS on the intestinal microbiome structure
    
  